Hepatitis C, interferon, and risk of rejection after liver transplantation

被引:19
作者
Samuel, D [1 ]
机构
[1] Univ Paris Sud, Hop Paul Brousse, Ctr Hepatobiliare, F-94800 Villejuif, France
关键词
D O I
10.1002/lt.20194
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:868 / 871
页数:4
相关论文
共 26 条
[1]   Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin [J].
Ahmad, J ;
Dodson, SF ;
Demetris, AJ ;
Fung, JJ ;
Shakil, AO .
LIVER TRANSPLANTATION, 2001, 7 (10) :863-869
[2]   Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study [J].
Alberti, AB ;
Belli, LS ;
Airoldi, A ;
de Carlis, L ;
Rondinara, G ;
Minola, E ;
Vangeli, M ;
Cernuschi, A ;
D'Amico, M ;
Forti, D ;
Pinzello, G .
LIVER TRANSPLANTATION, 2001, 7 (10) :870-876
[3]   Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].
Berenguer, M ;
Prieto, M ;
Rayón, JM ;
Mora, J ;
Pastor, M ;
Ortiz, V ;
Carrasco, D ;
San Juan, F ;
Burgueño, MDJ ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2000, 32 (04) :852-858
[4]   HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].
Berenguer, M ;
Ferrell, L ;
Watson, J ;
Prieto, M ;
Kim, M ;
Rayón, M ;
Córdoba, J ;
Herola, A ;
Ascher, N ;
Mir, J ;
Berenguer, J ;
Wright, TL .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684
[5]   Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence [J].
Bizollon, T ;
Ahmed, SNS ;
Radenne, S ;
Chevallier, M ;
Chevallier, P ;
Parvaz, P ;
Guichard, S ;
Ducerf, C ;
Baulieux, J ;
Zoulim, F ;
Trepo, C .
GUT, 2003, 52 (02) :283-287
[6]   Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].
Bizollon, T ;
Palazzo, U ;
Ducerf, C ;
Chevallier, M ;
Elliott, M ;
Baulieux, J ;
Pouyet, M ;
Trepo, C .
HEPATOLOGY, 1997, 26 (02) :500-504
[7]   Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation [J].
de Vera, ME ;
Smallwood, GA ;
Rosado, K ;
Davis, L ;
Martinez, E ;
Sharma, S ;
Stieber, AC ;
Heffron, TG .
TRANSPLANTATION, 2001, 71 (05) :678-686
[8]   ACUTE VANISHING BILE-DUCT SYNDROME AFTER INTERFERON THERAPY FOR RECURRENT HCV INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].
DOUSSET, B ;
CONTI, F ;
HOUSSIN, D ;
CALMUS, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (16) :1160-1161
[9]   Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination [J].
Dumoriter, J ;
Scoazec, JY ;
Chevallier, P ;
Boillot, O .
JOURNAL OF HEPATOLOGY, 2004, 40 (04) :669-674
[10]  
*ELTR, REG EUR LIV TRANSPL